Aperture AC

This prospectus dictates the economic floor, dilution profile, and incentive alignment that will govern public capital survival and sponsor behavior before any deal emerges. The stated $10.025 per share trust benchmark sets the liquidation and redemption baseline, directly determining whether public funds persist through an extension cycle or evaporate if the 12-month completion window expires. The explicit 36-month maximum extension ceiling caps uncertainty but forces accelerated deal sourcing near month twelve.

The revision recalibrates the baseline distribution mechanics by raising the disclosed pro rata redemption expectation to approximately $10.025 per share (without interest), which will directly dictate cash-out values for investors exercising redemption rights at the business combination vote or during any subsequent liquidation window.

The filing establishes the SPAC's IPO trust and redemption framework: approximately $90,225,000 (or $103,758,750 if the over-allotment option is fully exercised) would be deposited in trust, with an initially anticipated redemption price of approximately $10.025 per public share; the completion window is 12 months from the closing of the IPO, with no absolute deadline stated in the document; public shareholders get redemption rights in connection with a business combination or extension, subject to a 15% aggregate redemption cap if shareholder approval is sought; sponsor and insiders waive redemption and liquidation rights on founder shares and private placement units; and up to $1,500,000 of working capital loans may convert into private placement units. It also discloses digital-asset-infrastructure acquisition focus, management including CEO Calvin Kung and CFO Daniel Zhao, going-concern doubt as of December 31, 2025 ($44,390 cash and $205,605 working capital deficit), and prior SPAC experience in which Finnovate experienced roughly 99% public redemptions at its de-SPAC closing.

This comment directly targets the mechanics governing shareholder redemptions and trust accounting disclosures. By asking for clarification on scenarios where the redemption price could fall below $10 per share, the SEC Staff is scrutinizing how Aperture AC defines minimum liquidation value relative to actual trust distributions. The letter explicitly invokes Rules 460 and 461 regarding requests for acceleration, indicating that the SEC will not clear any effective date until this disclosure gap is resolved. Until Aperture AC files a response or a corrected Amendment No.

This filing is the registration statement for the SPAC's IPO, providing all material terms for investors. Key items: trust per share $10.00, deadline 12 months from closing, no specified maximum redemption threshold, sponsor shares at nominal price causing potential dilution, and the company has a going concern issue. The filing also discloses the digital asset industry focus and management's experience.

Resolving these drafting conflicts is a prerequisite for SEC effectiveness, which directly governs when the SPAC may advance toward a business combination or face mandatory liquidation. By contractually restricting tax-related trust distributions to interest earnings, the registrant safeguards the principal balance, protecting the $10.06 per-share redemption value from being drawn down for operational expenses.

Reconciling the 15-month versus 18-month completion window dictates whether Aperture AC must secure formal extensions or face mandatory redemptions ahead of its established deadline. Clarifying the tax withdrawal provision preserves the principal capital retained in trust, directly protecting the net amount available to shareholders who exercise redemption rights.

This filing sets the final terms of the SPAC's IPO and activates the trust account. For investors tracking this SPAC, the trust is now funded at $10.06 per share, meaning redemptions will be at that level. The 18-month deadline to find a deal runs from the closing date. The filing confirms that Calvin Kung, CEO of the sponsor, has a prior SPAC track record (Finnovate) that saw 99% redemptions. The document makes clear that the target focus is digital assets infrastructure. The sponsor and officers hold 27% of shares post-offering. The document also includes a going concern qualification in the audit report, which is standard for early-stage SPACs. The material changes from the initial filing include the finalization of the underwriters, pricing, and the trust amount.

This filing launches the SPAC's public offering, providing the first detailed disclosure of its terms, target strategy, sponsor economics, and potential conflicts. Investors evaluating the IPO should review the trust value ($10.00 per share), redemption mechanics, dilution from founder shares, and the 18-month deadline. The filing also reveals a prior SPAC (Finnovate) where 99% of shares were redeemed, which may inform sponsor conduct.

What changed: A routine compliance exhibit appended to a Schedule 13G filing, specifically comprising two Limited Powers of Attorney. Executed by Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC, these exhibits grant Takahiro Katsura and referenced executives the delegated authority to sign, execute, amend, and timely file Forms 13G and related submissions with the U.S. Securities and Exchange Commission regarding the institutions’ holdings and transactions in securities. The filing discloses no developments affecting APUR’s redemption deadline, trust account mechanics, extension procedures, target search progress, or sponsor conduct. Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC state only that they maintain a reporting obligation under Sections 13(d) and 13(g) of the Exchange Act. Neither the powers of attorney nor the exhibit schedules of subsidiaries reveal changes to ownership thresholds, trading activity, or any operational timeline for the SPAC. Why it matters: Because this document is strictly an administrative delegation of signing authority required to complete a regulatory disclosure, it provides zero signal regarding APUR’s capital preservation, investor redemption windows, conversion price adjustments, or business combination status. Institutional filers routinely attach such powers of attorney to satisfy SEC formatting rules, meaning this exhibit confirms procedural compliance rather than indicating any material shift in deal dynamics, trust value, or sponsor behavior.

What changed: Quarterly report (10-Q) for the period ended March 31, 2026, filed by Aperture AC, a blank-check company still searching for a target. The report covers the pre-IPO period (IPO closed May 22, 2026) and includes financial statements, MD&A, and disclosure of internal control weaknesses. IPO consummated after quarter end: $102.255M deposited into trust at $10.025 per share (not $10.06 as previously modeled). Sponsor forfeited 55,479 Class B shares. No business combination agreement has been entered. Management disclosed a material weakness in internal controls. The company had $22,691 cash and a $246,432 working capital deficit as of March 31, 2026, with substantial doubt about going concern. Why it matters: Investors should note the actual trust value per share ($10.025 vs. $10.06), the lack of any deal progress, the material weakness in controls, and the tight deadline of May 22, 2027. The SPAC is focusing on digital asset infrastructure targets but has not identified one.

What changed: SEC Form 4 insider ownership report for Aperture AC, documenting open-market equity dispositions filed by Goldman Sachs Group Inc and Goldman Sachs & Co. LLC, each identified as a 10% owner. As attested by Goldman Sachs Group Inc and Goldman Sachs & Co. LLC in this Form 4, Goldman Sachs Group Inc disposed of 1 share at $9.9 on 2026-06-15, retaining 1,057,644 shares afterward. Goldman Sachs & Co. LLC disposed of 22 shares at $9.9 on that same date, leaving 1,057,622 shares in position. A third line item in the report records a disposition of 25 shares at $9.9, resulting in a post-transaction holding of 1,057,597 shares. The filing contains no disclosure impacting the $10.06 trust/share value, the 2027-05-22 redemption deadline, extension votes, business combination progress, or sponsor conduct. Why it matters: Because the transactions execute at $9.9 per share against a reported trust value of $10.06 per share and involve negligible volume, they do not trigger redemption pressure, alter trust liquidity, or signal movement toward a merger or extension. The exhibit carries no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. As a routine secondary-market adjustment by a named institutional holder, it requires no calendar or dashboard action for redemption-tracking investors.

What changed: A routine compliance exhibit: SEC Form 3, an insider ownership report disclosing beneficial shareholdings in Aperture AC. The filing states that Goldman Sachs Group Inc. and Goldman Sachs & Co. LLC. each hold 1,057,597 shares indirectly, identifying themselves as 10% owners. The document discloses no purchases, sales, exercises, conversions, or transfers. Consequently, there is zero movement affecting the SPAC's redemption deadline tracking, the per-share trust metric ($10.06), extension triggers, business combination pipeline, or sponsor/guardian conduct. Why it matters: Beyond recording static indirect institutional positions, the document contains no claims regarding customer acquisition, revenue streams, addressable market size, corporate strategy, proprietary technology, partnership arrangements, active litigation, or management personnel changes. Because it registers only existing holdings without transactional activity or modified capital commitments, it does not shift investor redemption windows, alter trust distribution calculations, or indicate deal execution progress toward the 2027-05-22 deadline. Investors tracking cash preservation, extension voting, or sponsor alignment can treat this as administrative baseline reporting rather than a tactical catalyst.

What changed: Form 8-K Current Report (Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits) announcing the automatic corporate action to decouple APURU units into separately listed Class A ordinary shares and fractional rights. Per a press release dated June 9, 2026, authored and signed by CEO Calvin Kung, Aperture AC announced that its composite units (APURU) will cease trading on June 10, 2026. Commencing that date, the underlying Class A ordinary shares (ticker APUR, par value $0.0001 per share) and the attached rights (ticker APURR) will list and trade independently on the Nasdaq Capital Market. Management states each unit consisted of one Class A ordinary share and one right entitling the holder to receive one-fourth (1/4) of one Class A ordinary share upon consummation of an initial business combination. The filing emphasizes the separation is mandatory and automatic, requires no shareholder action, and warns that trades executed after market close on June 9 may fail to settle before the split, potentially depriving recent buyers of their associated rights. Why it matters: This event mechanically shifts the tradable instrument from composite units to distinct equity and derivative contracts, directly affecting liquidity routing, price discovery, and the exact security composition outstanding if public shareholders later exercise redemption or conversion rights ahead of a merger vote. The filing contains no updates regarding the May 22, 2027 liquidation deadline, trust account balance per share, extension proposals, target acquisition pipeline, or sponsor governance. Because no business combination has been identified and no trust-related disclosures are included, the submission primarily serves as a structural housekeeping notice that clarifies what instruments will remain active and exercisable while the company continues its SEARCHING status.

What changed: Routine compliance exhibit: a Joint Filing Agreement attached to a Schedule 13D beneficial ownership report. No mechanical shifts occur to the redemption calendar, trust accounting, extension triggers, or business combination trajectory. As of June 1, 2026, Aperture Sponsor LLC and Calvin Kung executed an agreement to jointly report beneficial ownership of Class A ordinary shares, $0.0001 par value, measured as of May 22, 2026. Each Party represents eligibility to utilize Schedule 13D, allocates responsibility for timely submissions and accuracy of self-reported data, retains liability for inaccuracies pertaining to the other Party that they know or should know, and designates Calvin Kung to sign all required Schedule 13D filings and amendments on behalf of both organizations. Why it matters: Because the attachment functions purely as an administrative coordination tool, it supplies no data on customer contracts, revenue streams, addressable markets, strategic pivots, technological developments, third-party partnerships, pending litigation, or executive appointments. The Parties themselves assert only filing logistics and accuracy responsibilities. Without an accompanying structured holder table, exact share quantities and percentage thresholds remain absent, meaning investors cannot quantify any shift in controlling stakes or sponsor dilution relative to outstanding public floats. While the agreement confirms continuous regulatory compliance and aligned reporting duties ahead of the active search phase, it neither alters trust distributions, redeems shares, finances a target, nor modifies sponsor conduct beyond standard SEC disclosure coordination. Accordingly, the filing introduces zero material adjustments to the redemption threshold, per-share trust calculation, or deadline schedule.

What changed: This document is a routine compliance exhibit, specifically an Exhibit A Joint Filing Agreement submitted alongside a Schedule 13G beneficial ownership report. No mechanics governing redemption deadlines, trust account distributions, extension windows, or deal progression have been altered or introduced. The filing merely formalizes that Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr. consent to file jointly under Rule 13d-1(k), with Fortmiller designated as the Managing Member and signing authority for each entity. Why it matters: Beyond verifying the administrative consolidation of reporting obligations, the document contains zero substantive claims regarding customers, revenue streams, target market size, corporate strategy, proprietary technology, partnership frameworks, active litigation, or executive personnel movements. Identifying how multiple Harraden vehicles aggregate their APUR equity positions remains operationally relevant for forecasting unified shareholder behavior should a business combination proposal surface before the search phase concludes, though no such timeline or catalyst is documented. All structural and administrative assertions are sourced directly from the joint filing agreement text dated May 29, 2026.

What changed: A Form 8-K current report accompanied by an audited balance sheet, confirming the consummation of the company's initial public offering (IPO) and private placement. Per Item 8.01 of the 8-K, Aperture AC closed its IPO on May 22, 2026, issuing 10,200,000 units at $10.00 each for $102,000,000 in gross proceeds, following a partial over-allotment exercise of 1,200,000 units. Concurrently, 311,000 private placement units were sold to the sponsor and underwriters for $3,110,000. $102,255,000 in combined proceeds was deposited into a U.S.-based trust account overseen by Continental Stock Transfer & Trust Company. The underwriters received a $1,530,000 cash fee and 450,000 representative shares. Total transaction costs reached $6,459,397. On the closing date, the sponsor surrendered 55,479 Class B founder shares. Management defined the Completion Window as ending May 22, 2027, establishing the trigger for automatic redemption and dissolution if unmet. Why it matters: This filing initiates the 12-month merger countdown, fixing the shareholder redemption calendar deadline at May 22, 2027. The audited balance sheet (Exhibit 99.1) places the trust account balance at $102,255,000, classifying the 10,200,000 public shares at a redemption value of $10.03 per share, while management's disclosures note the initially anticipated value is $10.025 per share. Auditor MaloneBailey, LLP issued a going concern warning, stating that the prescribed completion timeframe raises substantial doubt regarding the entity's viability. Note 1 discloses that no acquisition target has been identified and zero substantive negotiations have commenced. Governance terms include a capped administrative service contract of $2,083.33 per month payable to a sponsor affiliate, alongside a letter agreement where the sponsor waives redemption rights for founder shares and pledges to vote them in favor of any initial business combination. Each unit carries a Share Right converting to one-fourth of a public share upon deal close, which expires worthless absent a combination.

What changed: SEC Form 4 insider ownership report. Aperture Sponsor LLC and Chief Executive Officer Calvin Kung, each identified as a 10% owner, executed an open-market purchase of 223,000 shares at $10 per share on 2026-05-22, resulting in a post-transaction holding of exactly 223,000 shares for both entities. Why it matters: This disclosure documents sponsor and executive direct purchasing activity, which informs sponsor conduct and secondary-market capital commitment during the SEARCHING phase. It leaves the stated 2027-05-22 redemption deadline unaltered, introduces no trust account adjustments, triggers no extension voting protocols, and provides zero indication of business combination target progression. The filing contains no substantive assertions regarding customer acquisition, revenue streams, market sizing, strategic direction, technological capabilities, commercial partnerships, pending litigation, or operational milestones attributable to any named executive or company spokesperson. All cited figures and role attributions derive exclusively from the reporting persons’ regulatory submission.